WO2020032902A3 - Aksolotl blastema for use in the treatment of wounds and burns - Google Patents

Aksolotl blastema for use in the treatment of wounds and burns Download PDF

Info

Publication number
WO2020032902A3
WO2020032902A3 PCT/TR2019/050666 TR2019050666W WO2020032902A3 WO 2020032902 A3 WO2020032902 A3 WO 2020032902A3 TR 2019050666 W TR2019050666 W TR 2019050666W WO 2020032902 A3 WO2020032902 A3 WO 2020032902A3
Authority
WO
WIPO (PCT)
Prior art keywords
blastema
wounds
burns
treatment
aksolotl
Prior art date
Application number
PCT/TR2019/050666
Other languages
French (fr)
Other versions
WO2020032902A2 (en
Inventor
Turan DEMIRCAN
Gürkan Öztürk
İlknur KESKİN
Mustafa KESKİN
Hasan ÇELİK
Original Assignee
Istanbul Medipol Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istanbul Medipol Universitesi filed Critical Istanbul Medipol Universitesi
Publication of WO2020032902A2 publication Critical patent/WO2020032902A2/en
Publication of WO2020032902A3 publication Critical patent/WO2020032902A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/65Amphibians, e.g. toads, frogs, salamanders or newts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the use of axolotl blastema in the treatment of wounds and burns.
PCT/TR2019/050666 2018-08-10 2019-08-08 Aksolotl blastema for use in the treatment of wounds and burns WO2020032902A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201811635 2018-08-10
TRTR2018/11635 2018-08-10

Publications (2)

Publication Number Publication Date
WO2020032902A2 WO2020032902A2 (en) 2020-02-13
WO2020032902A3 true WO2020032902A3 (en) 2020-04-16

Family

ID=69415969

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050666 WO2020032902A2 (en) 2018-08-10 2019-08-08 Aksolotl blastema for use in the treatment of wounds and burns

Country Status (1)

Country Link
WO (1) WO2020032902A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136212A1 (en) * 2009-05-29 2010-12-02 Medizinische Hochschule Hannover Lipoxygenase and its use in wound healing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136212A1 (en) * 2009-05-29 2010-12-02 Medizinische Hochschule Hannover Lipoxygenase and its use in wound healing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEMIRCAN, TURAN ET AL.: "Axolotl cells and tissues enhances cutaneous wound healing in mice", JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE, vol. 33, no. 4, 2016, pages 229 - 237, XP055685887 *

Also Published As

Publication number Publication date
WO2020032902A2 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
MX2020001513A (en) Clec9a binding agents and use thereof.
WO2016134335A3 (en) Pvrig polypeptides and methods of treatment
MX2019015311A (en) Cannabidiolic acid esters compositions and uses thereof.
RS60410B1 (en) Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2018026722A8 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
GB201820450D0 (en) Compound and its use for the treatment of alpha1-antitryspin deficiency
EP4218736A3 (en) Compositions comprising 15-hepe
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
MX2018008644A (en) 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-deca ne derivatives.
TN2017000465A1 (en) The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc)
EP3806845A4 (en) Cannabinoid composition and methods of treatment using the same
PH12019500535A1 (en) 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12021550122A1 (en) Solubilized apyrases, methods and use
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
EP3452015A4 (en) Compositions and methods for treatment of inflammation or infection of the eye
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
EP3533451A4 (en) Application of paeoniflorin-6'-o-benzene sulfonate in medicine for treating sjögren's syndrome
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
EP3710010A4 (en) Use of hm4di in the treatment of seizure disorders
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
WO2020032902A3 (en) Aksolotl blastema for use in the treatment of wounds and burns
GB2569682B (en) Topical composition for use in the treatment of burns
EP3265108A4 (en) Peptides and compositions comprising same and uses thereof in the treatment of diseases

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19848761

Country of ref document: EP

Kind code of ref document: A2